Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("METAPLASIE MYELOIDE")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 17 of 17

  • Page / 1
Export

Selection :

  • and

TIEREXPERIMENTELLE MYELOFIBROSEN UND HYPEROSTOSEN IM VERGLEICH ZUR OSTEOMYELOSKLEROSE DES MENSCHEN = MYELOFIBROSES ET HYPEROSTOSES EN EXPERIMENTATION ANIMALE COMPAREES A L'OSTEOMYELOSCLEROSE DE L'HOMMEMARTIN H.1972; ZBL. ALLG. PATHOL. PATHOL. ANAT.; DTSCH.; DA. 1972; VOL. 116; NO 3-4; PP. 244-256; BIBL. 2P.Serial Issue

Myeloid metaplasia masquerading as a urethral caruncleBALOGH, K; O'HARA, C. J.The Journal of urology. 1986, Vol 135, Num 4, pp 789-790, issn 0022-5347Article

Extramedullary haematopoiesis in thyroid multinodular goitre preceding clinical evidence of agnogenic myeloid metaplasiaLEONI, F; FABBRI, R; PASCARELLA, A et al.Histopathology. 1996, Vol 28, Num 6, pp 559-562, issn 0309-0167, 3 p.Article

Reversal of bone marrow fibrosis and subsequent development of polycythemia in patients with myeloproliferative disordersTALARICO, L; WOLF, B. C; ARUNA KUMAR et al.American journal of hematology. 1989, Vol 30, Num 4, pp 248-253, issn 0361-8609Article

Influence of splenectomy on hemostasis in agnogenic myeloid metaplasiaBRENNER, B; TAVORI, S; TATARSKY, I et al.Haemostasis. 1987, Vol 17, Num 3, pp 141-146, issn 0301-0147Article

Myelofibrosis: a concise review of clinical and pathologic features and treatmentSMITH, R. E; CHELMOWSKI, M. K; SZABO, E. J et al.American journal of hematology. 1988, Vol 29, Num 3, pp 174-180, issn 0361-8609Article

Small intestine myeloid metaplasiaSCHREIBMAN, D; BRENNER, B; JACOBS, R et al.JAMA, the journal of the American Medical Association. 1988, Vol 259, Num 17, pp 2580-2582, issn 0098-7484Article

Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis-features of significance or the diagnosis of primary (essential) thrombocythaemiaTHIELE, J; SCHNEIDER, G; HOEPPNER, B et al.Virchows Archiv. A, Pathological anatomy and histopathology. 1988, Vol 413, Num 5, pp 407-417, issn 0174-7398Article

Cutaneous myeloid metaplasia with dysplastic features in idiopathic myelofibrosisPEDRO-BOTET, J; FELIU, E; ROZMAN, C et al.International journal of dermatology. 1988, Vol 27, Num 3, pp 179-180, issn 0011-9059Article

Pseudothromboembolism in myeloid metaplasiaGORDON, J. J; AUSTIN, M; KURTIDES, E. S et al.Annals of internal medicine. 1988, Vol 108, Num 6, pp 837-838, issn 0003-4819Article

Myelofibrosis with myeloid metaplasia following essential thrombocythaemiaLIBERATO, N. L; BAROSI, G; COSTA, A et al.Acta haematologica. 1989, Vol 82, Num 3, pp 150-153, issn 0001-5792Article

Splenomegaly as a cause of fecal incontinence: a new problem in an old diseaseROSEN, S. J; MORENO, J. M; HARRINGTON, W. J et al.Archives of internal medicine (1960). 1988, Vol 148, Num 8, pp 1874-1875, issn 0003-9926Article

A case of agnogenic myeloid metaplasia evolving into acute myelogenous leukemia associated with the development of trisomy 11 in bone marrow cellsDANG, C. V; STEIN, P. H; GRESS, D. R et al.American journal of hematology. 1985, Vol 19, Num 3, pp 285-288, issn 0361-8609Article

Successful treatment of essential thrombocythemia evolving into agnogenic myeloid metaplasia with interferon-αKIKAWA, Y; FUKUMOTO, Y; OBATA, K et al.Journal of pediatric hematology/oncology. 1998, Vol 20, Num 5, pp 463-466, issn 1077-4114Article

Coexistence of tetrasomy 8 and trisomy 8 in a case with myeloid metaplasia with myelofibrosisSOLE, F; DE PABLOS, J. M; WOESSNER, S et al.Cancer genetics and cytogenetics. 1997, Vol 94, Num 2, pp 147-150, issn 0165-4608Article

Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasiaMARVIN, K. S; SPELLBERG, R. D.Chest. 1993, Vol 103, Num 2, pp 642-644, issn 0012-3692Article

Thrombocytémie essentielle. Apport de la mutation V617F de JAK2 pour la stratégie diagnostique, la physiopathologie et les modalités évolutives = Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcomeBRIERE, Jean.Bulletin de l'Académie nationale de médecine. 2007, Vol 191, Num 3, pp 535-548, issn 0001-4079, 14 p.Article

  • Page / 1